HOME


Controversies in pharmacokinetics and dynamics Chairman: F Engbers (NL)	Pharmacoeconomics Chairman: L. Barvais (B)
The brain as a target in re-circulatory models. *R. Upton (AUS).*	Models of economic evaluation of anaesthesia. Speaker: Q. Piacevoli (I)
Different methods to estimate the keO. J. Bruhn (D)	Practical pharmacoeconomics with TIVA. Speaker: L. Rowe (UK)
Choosing a pharmaco-dynamic model for clinical practice N. Sutcliffe (UK)	Prize winning Posters:
	The Influence of the dose on the Time to Peak Effect of Propofol:Preliminary Results Farid Garoud, Pierre-Yves Leuquueux, Gilbert Bejjani, Luc Barvais
	* Effect Site Concentration During Propofol TCI Sedation A Comparison Of Sedation Score With Two Pharmacokinetic Models* Barakat A Sutcliffe N Schwab M
	The speed of induction affects the plasma-effect site equilibration rate constant (ke0) calculated with electroencephalographic derived indices. Luis I. Cortínez MD, Pablo Sepulveda MD, Gastón Núñez MD, Alejandro Recart MD
Intravenous anaesthesia and postoperative pain Chairman: F. Servin (FR)	Intravenous sedation in intensive care patients Chairman: J. Raeder (B)
Molecular basis of opioid pharmacology in inflammatory pain. *J. Garzón (E)*	Can EEG analyses be used to determine sedation levels in ICU? Speaker: X. Capdevilla (F)
Postoperative hyperalgesia: evaluation and treatment. B. Guignard (F)	Hypnotics for ICU sedation. Speaker: L. Berggren (S)
Managing opioid side-effects in clinical practice. *A. Borgeat (CH)*	The role of remifentanil versus other opioids in ICU sedation. Speaker: A. Dahaba (A)
Key note lecture Chairman: S.Schraag
Current concepts on the mechanism of general anaesthetics Speaker : J Antognini